
STERIS plc company profile
$264.32+4.29%Close 13 Nov 2026
About STERIS plc
STERIS provides products and services that support patient care, with an emphasis on infection prevention. Its Healthcare segment sells consumables, endoscopy accessories, capital equipment such as sterilizers and surgical tables, and services including equipment maintenance, instrument repair and outsourced reprocessing to healthcare providers, mainly for sterile processing departments and procedural areas. Its Applied Sterilization Technologies segment offers contract sterilization and laboratory testing, along with sterilization equipment and control systems, for medical device and pharmaceutical manufacturers. Its Life Sciences segment supplies detergents, disinfectants, sterilizers, water and steam generators, and maintenance services to biopharmaceutical and medical device manufacturers. The company sells to Customers in many countries and operates in the Americas, Europe and Asia.
A summary of the business section of the company's latest annual report, filed 29 May 2026.
Company facts
| Ticker | STE · NYSE |
|---|
| Sector | Medical devices |
|---|
| Industry | Health Care Equipment |
|---|
| Index | S&P 500 |
|---|
| Fiscal year ends | 31 March |
|---|
| Reporting currency | USD |
|---|
| CIK | 1757898 |
|---|
| Latest annual report | 10-K, filed 29 May 2026 |
|---|
Officers and directors
| Name | Role | Shares owned | Latest Form 4 |
|---|
| Daniel A. Carestio | President and CEO · Director | 354K | Sale under a 10b5-1 plan, 5 Jun 2026 |
|---|
| Michael J. Tokich | Sr. Vice Pres., CFO | 180K | Shares withheld for tax, 4 Jun 2025 |
|---|
| J. Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | 157K | Sale under a 10b5-1 plan, 15 Jun 2026 |
|---|
| Richard C. Breeden | Director | 91.5K | Option exercise, 2 Jun 2026 |
|---|
| Cary L. Majors | SVP and President, Healthcare | 59.9K | Shares withheld for tax, 2 Jun 2026 |
|---|
| Dr. Mohsen M. Sohi | Director | 56.5K | Option exercise, 10 Nov 2026 |
|---|
| Mary Clare Fraser | SVP & Chief HRO | 42.4K | Shares withheld for tax, 4 Jun 2026 |
|---|
| Karen L. Burton | Sr. Vice Pres., CFO | 30.8K | Option exercise, 11 Nov 2026 |
|---|
| Cynthia L. Feldmann | Director | 20.7K | Open-market sale, 5 Mar 2026 |
|---|
| Tamaro Renato | V.P. & Corporate Treasurer | — | Shares withheld for tax, 4 Jun 2026 |
|---|
| Madsen Julia | Sr. VP and GM, Life Sciences | — | Shares withheld for tax, 4 Jun 2026 |
|---|
| Kohler Kenneth E | SVP & GM, AST | — | Shares withheld for tax, 4 Jun 2026 |
|---|
| McGowan Lindsey | VP, Chf. Comp. & Quality Offc. | — | Shares withheld for tax, 2 Jun 2026 |
|---|
Holdings as the latest proxy statement states them, all forms counted; the latest Form 4 line each filed. People appointed since the proxy are listed from their Form 4 filings.
STE in the terminal
The business section of every annual report, officers' holdings and trades, and the company's filings as they arrive.